Dietary xenoestrogens differentially impair 3T3-L1 preadipocyte differentiation and persistently affect leptin synthesis

Waring, 2005, Endocrine disrupters: a human risk?, Mol. Cell. Endocrinol., 244, 2, 10.1016/j.mce.2005.02.007 Newbold, 2007, Developmental exposure to endocrine disruptors and the obesity epidemic, Reprod. Toxicol., 23, 290, 10.1016/j.reprotox.2006.12.010 Heindel, 2003, Endocrine disruptors and the obesity epidemic, Toxicol. Sci., 76, 247, 10.1093/toxsci/kfg255 Bouchard, 1993, Genetic and nongenetic determinants of regional fat distribution, Endocr. Rev., 14, 72, 10.1210/edrv-14-1-72 Cooke, 2004, Role of estrogens in adipocyte development and function, Exp. Biol. Med. (Maywood), 229, 1127, 10.1177/153537020422901107 Dieudonne, 2000, Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor gamma2, Endocrinology, 141, 649, 10.1210/en.141.2.649 Ntambi, 2000, Adipocyte differentiation and gene expression, J. Nutr., 130, 3122S, 10.1093/jn/130.12.3122S Tang, 2004, Sequential gene promoter interactions of C/EBPbeta, C/EBPalpha, and PPARgamma during adipogenesis, Biochem. Biophys. Res. Commun., 319, 235, 10.1016/j.bbrc.2004.04.176 Feve, 2005, Adipogenesis: cellular and molecular aspects, Best Pract. Res. Clin. Endocrinol. Metab., 19, 483, 10.1016/j.beem.2005.07.007 Fu, 2005, A nuclear receptor atlas: 3T3-L1 adipogenesis, Mol. Endocrinol., 19, 2437, 10.1210/me.2004-0539 Harmon, 2001, Differential effects of flavonoids on 3T3-L1 adipogenesis and lipolysis, Am. J. Physiol. Cell Physiol., 280, C807, 10.1152/ajpcell.2001.280.4.C807 Masuno, 2003, Effect of 4-nonylphenol on cell proliferation and adipocyte formation in cultures of fully differentiated 3T3-L1 cells, Toxicol. Sci., 75, 314, 10.1093/toxsci/kfg203 Masuno, 2002, Bisphenol A in combination with insulin can accelerate the conversion of 3T3-L1 fibroblasts to adipocytes, J. Lipid Res., 43, 676, 10.1016/S0022-2275(20)30108-5 Shen, 2006, Differential effects of isoflavones, from Astragalus membranaceus and Pueraria thomsonii, on the activation of PPARalpha, PPARgamma, and adipocyte differentiation in vitro, J. Nutr., 136, 899, 10.1093/jn/136.4.899 Tang, 2003, Mitotic clonal expansion: a synchronous process required for adipogenesis, Proc. Natl. Acad. Sci. U.S.A., 100, 44, 10.1073/pnas.0137044100 Pelissero, 1991, The estrogenic activity of certain phytoestrogens in the Siberian sturgeon Acipenser baeri, J. Steroid Biochem. Mol. Biol., 38, 293, 10.1016/0960-0760(91)90100-J Soto, 1986, Control of cell proliferation: evidence for negative control on estrogen-sensitive T47D human breast cancer cells, Cancer Res., 46, 2271 Rodriguez-Cuenca, 2005, Depot differences in steroid receptor expression in adipose tissue: possible role of the local steroid milieu, Am. J. Physiol. Endocrinol. Metab., 288, E200, 10.1152/ajpendo.00270.2004 Bandyopadhyay, 2006, Attenuation of osteoclastogenesis and osteoclast function by apigenin, Biochem. Pharmacol., 72, 184, 10.1016/j.bcp.2006.04.018 Borenfreund, 1984, A simple quantitative procedure using monolayer cultures for cytotoxicity assays (HTD/NR-90), J. Tissue Culture Methods, 9, 7, 10.1007/BF01666038 Rat, 1994, New in vitro fluorimetric microtitration assays for toxicological screening of drugs, Cell Biol. Toxicol., 10, 329, 10.1007/BF00755779 Kissane, 1958, The fluorometric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system, J. Biol. Chem., 233, 184, 10.1016/S0021-9258(19)68051-8 Vankoningsloo, 2005, Mitochondrial dysfunction induces triglyceride accumulation in 3T3-L1 cells: role of fatty acid beta-oxidation and glucose, J. Lipid Res., 46, 1133, 10.1194/jlr.M400464-JLR200 Gregoire, 1998, Understanding adipocyte differentiation, Physiol. Rev., 78, 783, 10.1152/physrev.1998.78.3.783 Stroheker, 2004, Steroid activities comparison of natural and food wrap compounds in human breast cancer cell lines, Food Chem. Toxicol., 42, 887, 10.1016/j.fct.2004.01.012 Fernandez, 2004, Assessment of total effective xenoestrogen burden in adipose tissue and identification of chemicals responsible for the combined estrogenic effect, Anal. Bioanal. Chem., 379, 163, 10.1007/s00216-004-2558-5 Masuno, 2005, Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway, Toxicol. Sci., 84, 319, 10.1093/toxsci/kfi088 Pinzone, 2004, Molecular and cellular determinants of estrogen receptor alpha expression, Mol. Cell. Biol., 24, 4605, 10.1128/MCB.24.11.4605-4612.2004 Dos Santos, 2002, Rapid nongenomic E2 effects on p42/p44 MAPK, activator protein-1, and cAMP response element binding protein in rat white adipocytes, Endocrinology, 143, 930, 10.1210/en.143.3.930 Harmon, 2002, Genistein inhibits CCAAT/enhancer-binding protein beta (C/EBPbeta) activity and 3T3-L1 adipogenesis by increasing C/EBP homologous protein expression, Biochem. J., 367, 203, 10.1042/bj20020300 Fujita-Yamaguchi, 1988, Characterization of receptor tyrosine-specific protein kinases by the use of inhibitors. Staurosporine is a 100-times more potent inhibitor of insulin receptor than IGF-I receptor, Biochem. Biophys. Res. Commun., 157, 955, 10.1016/S0006-291X(88)80967-7 Dang, 2003, Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein, J. Biol. Chem., 278, 962, 10.1074/jbc.M209483200 Halleux, 1998, Multihormonal control of ob gene expression and leptin secretion from cultured human visceral adipose tissue: increased responsiveness to glucocorticoids in obesity, J. Clin. Endocrinol. Metab., 83, 902, 10.1210/jc.83.3.902 Leroy, 1996, Expression of ob gene in adipose cells. Regulation by insulin, J. Biol. Chem., 271, 2365, 10.1074/jbc.271.5.2365 Kristensen, 1999, Regulation of leptin by steroid hormones in rat adipose tissue, Biochem. Biophys. Res. Commun., 259, 624, 10.1006/bbrc.1999.0842 Patel, 2003, Differential regulation of lipogenesis and leptin production by independent signaling pathways and rosiglitazone during human adipocyte differentiation, Diabetes, 52, 43, 10.2337/diabetes.52.1.43